ABCELLERA BIOLOGICS (8QQ) — Free Cash Flow Generation Index

Latest as of December 2022: 0.74x

ABCELLERA BIOLOGICS (8QQ) has a Free Cash Flow Generation Index of 0.74x as of December 2022. Free cash flow of €204.70 Million represents 1% of operating cash flow (€277.36 Million). See ABCELLERA BIOLOGICS short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

0.74x

Free Cash Flow / Operating CF

Free Cash Flow

€204.70 Million

EUR

Operating Cash Flow

€277.36 Million

EUR

Capital Expenditures

€72.66 Million

EUR

ABCELLERA BIOLOGICS Free Cash Flow Generation Index (2021–2022)

Historical FCF Generation Index trend for ABCELLERA BIOLOGICS across 2 annual periods. Explore ABCELLERA BIOLOGICS cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for ABCELLERA BIOLOGICS (2021–2022)

Year-by-year Free Cash Flow Generation Index for ABCELLERA BIOLOGICS. For the full company profile including market capitalisation, see 8QQ company net worth.

Year	FCG Index	Free Cash Flow (EUR)	Operating CF	Capital Expenditures	YoY Change
2022	0.74x	€204.70 Million	€277.36 Million	€72.66 Million	▼ -3.0%
2021	0.76x	€186.13 Million	€244.58 Million	€58.45 Million	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).